“Brentuximab Vedotin Effects on Prognosis of Refractory and Relapsed Peripheral T-Cell Lymphoma: A Systematic Review”. Revista de Medicina e Saúde de Brasília 7, no. 2 (January 5, 2019). Accessed September 23, 2026. https://portalrevistas.ucb.br/index.php/rmsbr/article/view/9251.